P-6755 Pazopanib, Hydrochloride Salt, >99%

Synonyms : [GW-786034]

Related Terms : [Armala] [Votrient]

Prices_reduced
  • Size
  • US $
  • £
  • ¥
  • 25 mg
  • 46
  • 41
  • 36
  • 5,000
  • Add to Cart Qty:
  • In stock
  • 50 mg
  • 62
  • 56
  • 49
  • 6,700
  • Add to Cart Qty:
  • In stock
  • 100 mg
  • 87
  • 79
  • 69
  • 9,400
  • Add to Cart Qty:
  • In stock
  • 200 mg
  • 117
  • 106
  • 93
  • 12,600
  • Add to Cart Qty:
  • In stock
  • 300 mg
  • 144
  • 130
  • 115
  • 15,500
  • Add to Cart Qty:
  • In stock
  • 500 mg
  • 192
  • 174
  • 153
  • 20,700
  • Add to Cart Qty:
  • In stock
  • 1 g
  • 247
  • 224
  • 197
  • 26,700
  • Add to Cart Qty:
  • In stock
  • 2 g
  • 390
  • 354
  • 312
  • 42,100
  • Add to Cart Qty:
  • In stock
  • 5 g
  • 775
  • 704
  • 620
  • 83,700
  • Add to Cart Qty:
  • In stock

Note: Our Euro, Pound, and Yen prices are revised regularly to account for currency exchange rate fluctuations.

To receive a Formal Quotation for catalog sizes of this product and/or any other products, please add them to your shopping cart and click on the “REQUEST A QUOTATION” box.
Click Here to Request a Quotation for Larger Quantities Free Shipping and Handling to the U.S. and 33 Other Countries
  • M.W. 473.98
  • C21H23N7O2S•HCl
  • [635702-64-6]

Select Lot Number to view Certificate of Analysis

View the SDS for this product

  • More than 250 labs worldwide have purchased Pazopanib or its salt forms from LC Labs (either directly from us or from our many distributors, many of whom resell under their own labels).
  • This research compound is the hydrochloride salt form of pazopanib; please see the other form of this product, Cat. No. [P-6706], Pazopanib, Free Base, for further technical information about both of these research compounds.
  • This pazopanib product is the hydrochloride salt, whose CAS number is given above. The CAS number of the free base form is 444731-52-6.
  • Pazopanib Hydrochloride Salt is the active ingredient in the drug products sold under the trade names Armala® and Votrient®. This drug is currently approved in at least one country for use in patients with advanced renal cell carcinoma and in patients with advanced soft tissue sarcoma who have received prior chemotherapy. THE PAZOPANIB HYDROCHLORIDE SALT COMPOUND SOLD BY LC LABORATORIES FOR RESEARCH IS NOT ARMALA® NOR VOTRIENT®, AND IS NOT FOR HUMAN USE.
  • Sold for laboratory or manufacturing purposes only; not for human, veterinary, food, or household use
  • This product is offered for R&D use in accordance with (i) 35 USC 271(e)+A13(1) in the U.S.; (ii) Section 69.1 of Japanese Patent Law in Japan; (iii) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (v) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (vi) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (vii) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (viii) such similar laws and rules as may apply in various other countries.
  • Not available in some countries; not available to some institutions; not available for some uses.
537